Skip to main content
OpenTrials
Completed

NCT Number: NCT05319262

Metabolic and Cognitive Consequences of Noise-induced Sleep Disturbance

This study will investigate the biological mechanisms linking sleep disruption by noise and the development of disease. In a laboratory sleep study, we will play traffic sounds of different types (road, rail and air) and noise levels during the night. We will also have nights with sound from so-called "white noise machines". These generate a low-level and continuous noise that may improve sleep by "masking" the traffic noises that would otherwise disturb sleep. We will also measure objective sleep quality and quantity, cognitive performance across multiple domains, self-reported sleep and wellbeing outcomes, and blood samples. Blood samples will be analysed to identify metabolic changes in different nights. Identifying biomarkers that are impacted by sleep fragmentation will establish the currently unclear pathways by which chronic noise exposure at night can lead to the development of diseases in the long term, especially cardiometabolic disorders.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Gothenburg

Gothenburg, Västra Götaland County, 42650, Sweden

About this study

The experimental sleep study has the overarching goal of deepening our understanding of experimentally-induced disruption of sleep and changes in metabolic and cognitive function, and to determine the efficacy of a potential non-pharmacological intervention to promote sleep. To this end, the study will address the following independent aims:

Aim 1: Determine associations between novel physiologic markers of sleep and metabolic and cognitive function. We will measure the sleep of healthy volunteers using novel and classical indictors of sleep architecture. Each morning we will obtain blood samples for metabolomics analysis and administer a neurocognitive test battery.

Aim 2: Determine the biological and neurobehavioral consequences of noise-disrupted sleep. We will compare effects on sleep, metabolomics and cognitive function between quiet nights and nights with traffic noise.

Aim 3: Evaluate the effects of continuous pink noise throughout the night. Sub-aim 1: To determine if continuous noise (pink noise) per se improves or disturbs sleep, we will investigate changes in novel and classical indictors of sleep architecture and disturbance induced by pink noise relative to quiet baseline nights. Sub-aim 2: To determine if pink noise reduces sleep disturbance by traffic noise, we will investigate changes in sleep fragmentation and continuity, and cortical and autonomic arousal, from nights with both traffic noise and pink noise compared to nights with traffic noise only.

The study will be conducted at in the University of Gothenburg sound environment laboratory (SEL). The SEL is a high fidelity research laboratory equipped to simulate a typical apartment, including three individually light-, sound- and vibration-isolated private bedrooms. Ceiling mounted speakers in each room allow us to create a realistic acoustic environment by transmitting sound exposures from the control room to each bedroom individually.

This study has a prospective within-subjects cross-over design. Participants (N=12) will each spend five consecutive nights in the SEL with a sleep opportunity between 23:00-07:00. Daytime sleep will be prohibited, confirmed with measures of daytime activity via wrist actigraphy monitors worn continuously throughout the study. Three subjects will take part concurrently, in separate bedrooms. The first night is a habituation period to the study protocol and for familiarisation with the test procedures. Study nights 2-5 are the experimental nights and will be randomly assigned across participants using a Latin square design to avoid first-order carryover effects. Each subject will be exposed to one night of each of the following:

Quiet night: No noise will be played, serving as a control night to assess individual baseline sleep, metabolic profile, and cognitive performance; Traffic noise night to determine consequences of noise-disrupted sleep; Pink noise night: To determine impact of continuous pink noise on sleep; Traffic + pink noise night: simultaneous traffic and pink noise at the same sound pressure levels as in the traffic-only and pink noise-only nights, to determine sleep-protecting effects of pink noise in the face of traffic noise.

Each night we will record physiologic sleep with polysomnography (PSG) and cardiac activity with electrocardiography (ECG). Each study morning, subjects will provide a 2ml blood sample, complete cognitive testing and answer questionnaires and will depart the SEL to follow their normal daytime routine. They will return to the SEL at 20:00 each evening to prepare for sleep measurements. Caffeine will be prohibited after 15:00 and alcohol will be prohibited at all times. Because sound-induced auditory fatigue may be affected by noise exposure during participant's normal routines,60 they will wear a noise dosimeter during the week of the study to record their daytime noise exposure. Because extreme and/or variable dietary behaviour can affect the metabolome/lipoprotein profile, participants will be given guidance that they should eat a similar evening meal on each day of the laboratory study, confirmed with a food diary, The actual meal itself can be different for different study participants, because the study has a within-subjects design.

Sleep will be recorded with ambulatory polysomnography (PSG) and cardiac activity with electrocardiography (ECG) and finger pulse photoplethysmogram. Data are recorded offline onto the sleep recorder, and will be downloaded and checked every study morning to ensure data quality. In addition to traditional sleep analysis performed by the research group at the University of Gothenburg, raw PSG data will be used to calculate the Odds Ratio Project, a novel metric of sleep depth and stability.

Each study morning subjects will provide a 2 ml blood sample for plasma metabolomics analysis. To ensure reliable data, blood samples will be taken at the same time every day to mitigate circadian effects, before eating or drinking anything except water, and each sample will be handled in the same way i.e. centrifuged, aliquoted and stored in -80C freezers. Subjects will eat the same food each study evening to mitigate within-subject dietary effects on the blood metabolome.

Each morning, subjects will complete a computerised cognitive test battery taking approximately 20 minutes, that includes 10 tests across a range of cognitive domains (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance). Cognition data will be analysed to determine key measures of cognitive speed and accuracy, adjusting for practice effects and the difficulty of the stimulus set.

Subjects will complete a battery of one-time validated questionnaires to measure their general health (SF-36), chronotype, noise sensitivity, habitual sleep quality, environmental sensitivity, and annoyance and sleep disturbance by noise. Subjects will also answer a questionnaire each study evening and morning, involving questions on sleepiness (Karolinska Sleepiness Scale), auditory fatigue, sleep disturbance by noise, and validated sleep and disturbance questions.

Subjects will wear a noise dosimeter during the week of the study to record their daytime noise exposure (sound pressure level only, no actual sound recordings).

Participants will wear a wrist actigraphy monitor continuously throughout the study period, and also for the week before the study, to confirm habitual sleep-wake times and to measure physical activity levels.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • live in or around the city of Gothenburg area (Sweden)

Exclusion criteria

  • aged <18 or >30 years;
  • habitual sleep and wake timings more than ±1 hour different from the study sleep times (i.e. habitual sleep time should be 22:00-00:00 and habitual wake time should be 06:00-08:00);
  • BMI>25 kg/m2;
  • regular sleep medication use (prescribed or "over-the-counter");
  • poor hearing acuity (measured during screening via pure tone audiometry);
  • diagnosed with sleep disorders;
  • indications of sleep apnea on the STOP-BANG questionnaire;
  • shift work;
  • smoking, vaping, snus, or other nicotine use;
  • pre-existing use of "white noise machines" as a sleep aid.

Treatment and study plan

Pink noise exposure

Radiation

Continuous pink noise sound exposure at 45 dBA, throughout the whole night

Traffic noise

Radiation

120 traffic noise events (40 each of road, rail and aircraft), introduced at maximum sound pressure levels ranging between 45-65 dB LAS.max.

Primary outcomes

  1. Metabolomics and lipids

    Time frame: On each of the five study mornings

    Concentrations of 41 metabolites, including amino acids, amines, alcohols, carboxylic acids, choline, keto acids, sugars, and sulfones. Lipoprotein profile, including concentrations of triglycerides, cholesterol, phospholipids, and apolipoproteins.

  2. Baseline total sleep time

    Time frame: During the Control night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  3. Total sleep time during exposure to nocturnal traffic

    Time frame: During the traffic noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  4. Total sleep time during exposure to pink noise

    Time frame: During the pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  5. Total sleep time during exposure to traffic noise + pink noise

    Time frame: During the Traffic noise + pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  6. Total amount of baseline N1 sleep

    Time frame: During the Control night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  7. Total amount of baseline N2 sleep

    Time frame: During the Control night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  8. Total amount of baseline N3 sleep

    Time frame: During the Control night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  9. Total amount of baseline rapid eye movement (REM) sleep

    Time frame: During the Control night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  10. Total amount of N1 sleep during exposure to nocturnal traffic

    Time frame: During the traffic noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  11. Total amount of N2 sleep during exposure to nocturnal traffic

    Time frame: During the traffic noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  12. Total amount of N3 sleep during exposure to nocturnal traffic

    Time frame: During the traffic noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  13. Total amount of rapid eye movement (REM) sleep during exposure to nocturnal traffic

    Time frame: During the traffic noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  14. Total amount of N1 sleep during exposure to pink noise

    Time frame: During the pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  15. Total amount of N2 sleep during exposure to pink noise

    Time frame: During the pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  16. Total amount of N3 sleep during exposure to pink noise

    Time frame: During the pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  17. Total amount of rapid eye movement (REM) sleep during exposure to pink noise

    Time frame: During the pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  18. Total amount of N1 sleep during exposure to traffic noise + pink noise

    Time frame: During the Traffic noise + pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  19. Total amount of N2 sleep during exposure to traffic noise + pink noise

    Time frame: During the Traffic noise + pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  20. Total amount of N3 sleep during exposure to traffic noise + pink noise

    Time frame: During the Traffic noise + pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  21. Total amount of rapid eye movement (REM) sleep during exposure to traffic noise + pink noise

    Time frame: During the Traffic noise + pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  22. Baseline wakefulness after sleep onset (WASO)

    Time frame: During the Control night

    Total number of minutes awake during the night after the first appearance of sleep of any stage. Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  23. Wakefulness after sleep onset (WASO) during exposure to nocturnal traffic

    Time frame: During the Traffic noise night

    Total number of minutes awake during the night after the first appearance of sleep of any stage. Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  24. Wakefulness after sleep onset (WASO) during exposure to pink noise

    Time frame: During the Pink noise night

    Total number of minutes awake during the night after the first appearance of sleep of any stage. Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  25. Wakefulness after sleep onset (WASO) during exposure to traffic noise + pink noise

    Time frame: During the Traffic noise + pink noise night

    Total number of minutes awake during the night after the first appearance of sleep of any stage. Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  26. Baseline number of awakenings

    Time frame: During the Control night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  27. Number of awakenings during exposure to nocturnal traffic

    Time frame: During the Traffic noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  28. Number of awakenings during exposure to pink noise

    Time frame: During the Pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  29. Number of awakenings during exposure to traffic noise + pink noise

    Time frame: During the Traffic noise + pink noise night

    Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines

  30. Baseline sleep onset latency (SOL)

    Time frame: During the Control night

    Defined as the time from lights out to the first epoch of sleep measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.

  31. Sleep onset latency (SOL) during exposure to nocturnal traffic

    Time frame: During the Traffic noise night

    Defined as the time from lights out to the first epoch of sleep measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.

  32. Sleep onset latency (SOL) during exposure to pink noise

    Time frame: During the Pink noise night

    Defined as the time from lights out to the first epoch of sleep measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.

  33. Sleep onset latency (SOL) during exposure to nocturnal traffic and pink noise

    Time frame: During the Traffic noise + Pink noise night

    Defined as the time from lights out to the first epoch of sleep measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.

  34. Baseline sleep efficiency

    Time frame: During the Control night

    Defined as the percentage of time in bed spent in a non-wake sleep stage, measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.

  35. Sleep efficiency during exposure to nocturnal traffic

    Time frame: During the Traffic noise night

    Defined as the percentage of time in bed spent in a non-wake sleep stage, measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.

  36. Sleep efficiency during exposure to pink noise

    Time frame: During the Pink noise night

    Defined as the percentage of time in bed spent in a non-wake sleep stage, measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.

  37. Sleep efficiency during exposure to nocturnal traffic and pink noise

    Time frame: During the Traffic noise + pink noise night

    Defined as the percentage of time in bed spent in a non-wake sleep stage, measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.

  38. Baseline sleep depth assessed using the odds ratio product (ORP)

    Time frame: During the Control night

    Average ORP over the full night, from 0 (never occurs during wake) to 2.5 (only occurs during wake). Derived via polysomnography/EEG measurements.

  39. Sleep depth assessed using the odds ratio product (ORP) during exposure to nocturnal traffic

    Time frame: During the Traffic noise night

    Average ORP over the full night, from 0 (never occurs during wake) to 2.5 (only occurs during wake). Derived via polysomnography/EEG measurements.

  40. Sleep depth assessed using the odds ratio product (ORP) during exposure to pink noise

    Time frame: During the Pink noise night

    Average ORP over the full night, from 0 (never occurs during wake) to 2.5 (only occurs during wake). Derived via polysomnography/EEG measurements.

  41. Sleep depth assessed using the odds ratio product (ORP) during exposure to traffic noise and pink noise

    Time frame: During the Traffic noise + pink noise night

    Average ORP over the full night, from 0 (never occurs during wake) to 2.5 (only occurs during wake). Derived via polysomnography/EEG measurements.

  42. Spontaneous maximal change of odds ratio product (ORP)

    Time frame: During the Control night

    Primary measure of acute sleep disruption by noise, calculated as the difference between the ORP in the 30s prior to noise onset and the maximum ORP during traffic noise. Averaged over 120 sham noise events during the night.

  43. Maximal change of odds ratio product (ORP) during exposure to traffic noise events

    Time frame: During the Traffic noise night

    Primary measure of acute sleep disruption by noise, calculated as the difference between the ORP in the 30s prior to noise onset and the maximum ORP during traffic noise. Averaged over all 120 noise events during the night.

  44. Maximal change of odds ratio product (ORP) during exposure to traffic noise events

    Time frame: During the Traffic noise + pink noise night

    Primary measure of acute sleep disruption by noise, calculated as the difference between the ORP in the 30s prior to noise onset and the maximum ORP during traffic noise. Averaged over all 120 noise events during the night.

  45. Spontaneous change of odds ratio product (ORP) during exposure to pink noise

    Time frame: During the Pink noise night

    Primary measure of acute sleep disruption by noise, calculated as the difference between the ORP in the 30s prior to noise onset and the maximum ORP during traffic noise. Averaged over 120 sham noise events during the night.

  46. Baseline morning neurobehavioural speed

    Time frame: In the morning immediately after the Control night

    Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)

  47. Morning neurobehavioural speed after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)

  48. Morning neurobehavioural speed after exposure to pink noise

    Time frame: In the morning immediately after the Pink noise night

    Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)

  49. Morning neurobehavioural speed after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)

  50. Baseline morning neurobehavioural accuracy

    Time frame: In the morning immediately after the Control night

    Average of one key accuracy indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)

  51. Morning neurobehavioural accuracy after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Average of one key accuracy indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)

  52. Morning neurobehavioural accuracy after exposure to pink noise

    Time frame: In the morning immediately after the Pink noise night

    Average of one key accuracy indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)

  53. Morning neurobehavioural accuracy after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Average of one key accuracy indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)

  54. Baseline evening neurobehavioural speed

    Time frame: In the evening of the day following the Control night

    Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)

  55. Evening neurobehavioural speed after exposure to nocturnal traffic

    Time frame: In the evening of the day following the Traffic noise night

    Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)

  56. Evening neurobehavioural speed after exposure to pink noise

    Time frame: In the evening of the day following the Pink noise night

    Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)

  57. Evening neurobehavioural speed after exposure to nocturnal traffic and pink noise

    Time frame: In the evening of the day following the Traffic noise + pink noise night

    Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)

  58. Baseline evening neurobehavioural accuracy

    Time frame: In the evening of the day following the Control night

    Average of one key speed indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)

  59. Evening neurobehavioural accuracy after exposure to nocturnal traffic

    Time frame: In the evening of the day following the Traffic noise night

    Average of one key speed indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)

  60. Evening neurobehavioural accuracy after exposure to pink noise

    Time frame: In the evening of the day following the Pink noise night

    Average of one key speed indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)

  61. Evening neurobehavioural accuracy after exposure to nocturnal traffic and pink noise

    Time frame: In the evening of the day following the Traffic noise + pink noise night

    Average of one key speed indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)

  62. Baseline Ethanol concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  63. Baseline Trimethylamine-N-oxide concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  64. Baseline 2-Aminobutyric acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  65. Baseline Alanine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  66. Baseline Asparagine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  67. Baseline Creatine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  68. Baseline Creatinine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  69. Baseline Glutamic acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  70. Baseline Glutamine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  71. Baseline Glycine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  72. Baseline Histidine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  73. Baseline Isoleucine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  74. Baseline Leucine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  75. Baseline Lysine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  76. Baseline Methionine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  77. Baseline N,N-Dimethylglycine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  78. Baseline Ornithine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  79. Baseline Phenylalanine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  80. Baseline Proline concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  81. Baseline Sarcosine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  82. Baseline Threonine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  83. Baseline Tyrosine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  84. Baseline Valine concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  85. Baseline 2-Hydroxybutyric acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  86. Baseline Acetic acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  87. Baseline Citric acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  88. Baseline Formic acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  89. Baseline Lactic acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  90. Baseline Succinic acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  91. Baseline Choline concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  92. Baseline 2-Oxoglutaric acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  93. Baseline 3-Hydroxybutyric acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  94. Baseline Acetoacetic acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  95. Baseline Acetone concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  96. Baseline Pyruvic acid concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  97. Baseline D-Galactose concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  98. Baseline Glucose concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  99. Baseline Glycerol concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  100. Baseline Dimethylsulfone concentration (mmol/L)

    Time frame: In the morning immediately after the Control night

    Determined from NMR analysis of blood plasma

  101. Ethanol concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  102. Trimethylamine-N-oxide concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  103. 2-Aminobutyric acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  104. Alanine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  105. Asparagine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  106. Creatine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  107. Creatinine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  108. Glutamic acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  109. Glutamine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  110. Glycine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  111. Histidine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  112. Isoleucine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  113. Leucine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  114. Lysine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  115. Methionine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  116. N,N-Dimethylglycine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  117. Ornithine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  118. Phenylalanine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  119. Proline concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  120. Sarcosine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  121. Threonine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  122. Tyrosine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  123. Valine concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  124. 2-Hydroxybutyric acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  125. Acetic acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  126. Citric acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  127. Formic acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  128. Lactic acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  129. Succinic acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  130. Choline concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  131. 2-Oxoglutaric acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  132. 3-Hydroxybutyric acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  133. Acetoacetic acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  134. Acetone concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  135. Pyruvic acid concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  136. D-Galactose concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  137. Glucose concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  138. Glycerol concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  139. Dimethylsulfone concentration (mmol/L) after exposure to nocturnal traffic

    Time frame: In the morning immediately after the Traffic noise night

    Determined from NMR analysis of blood plasma

  140. Ethanol concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  141. Trimethylamine-N-oxide concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  142. 2-Aminobutyric acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  143. Alanine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  144. Asparagine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  145. Creatine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  146. Creatinine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  147. Glutamic acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  148. Glutamine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  149. Glycine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  150. Histidine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  151. Isoleucine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  152. Leucine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  153. Lysine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  154. Methionine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  155. N,N-Dimethylglycine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  156. Ornithine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  157. Phenylalanine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  158. Proline concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  159. Sarcosine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  160. Threonine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  161. Tyrosine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  162. Valine concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  163. 2-Hydroxybutyric acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  164. Acetic acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  165. Citric acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  166. Formic acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  167. Lactic acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  168. Succinic acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  169. Choline concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  170. 2-Oxoglutaric acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  171. 3-Hydroxybutyric acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  172. Acetoacetic acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  173. Acetone concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  174. Pyruvic acid concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  175. D-Galactose concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  176. Glucose concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  177. Glycerol concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  178. Dimethylsulfone concentration (mmol/L) after exposure to nocturnal pink noise

    Time frame: In the morning immediately after the Pink noise night

    Determined from NMR analysis of blood plasma

  179. Ethanol concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  180. Trimethylamine-N-oxide concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  181. 2-Aminobutyric acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  182. Alanine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  183. Asparagine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  184. Creatine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  185. Creatinine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  186. Glutamic acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  187. Glutamine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  188. Glycine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  189. Histidine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  190. Isoleucine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  191. Leucine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  192. Lysine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  193. Methionine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  194. N,N-Dimethylglycine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  195. Ornithine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  196. Phenylalanine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  197. Proline concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  198. Sarcosine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  199. Threonine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  200. Tyrosine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  201. Valine concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  202. 2-Hydroxybutyric acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  203. Acetic acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  204. Citric acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  205. Formic acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  206. Lactic acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  207. Succinic acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  208. Choline concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  209. 2-Oxoglutaric acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  210. 3-Hydroxybutyric acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  211. Acetoacetic acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  212. Acetone concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  213. Pyruvic acid concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  214. D-Galactose concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  215. Glucose concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  216. Glycerol concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

  217. Dimethylsulfone concentration (mmol/L) after exposure to nocturnal traffic and pink noise

    Time frame: In the morning immediately after the Traffic noise + pink noise night

    Determined from NMR analysis of blood plasma

Secondary outcomes

  1. Cardiovascular activation in response to noise

    Time frame: Event-related, occurring within the time window of each discrete noise event, during each of the five study nights (23:00 to 07:00)

    Change in heart rate (ECG)

  2. Evening subjective sleepiness, assessed using the Karolinska Sleepiness Scale

    Time frame: Every study evening

    The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)

  3. Morning subjective sleepiness, assessed using the Karolinska Sleepiness Scale

    Time frame: Every study morning

    The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)

  4. Evening auditory fatigue

    Time frame: Every study evening

    Perceived auditory fatigue, self-reported on a 5-point verbal scale, from 1 - "Not at all" (best outcome) to 5 - "Extremely" (worst outcome)

  5. Morning auditory fatigue

    Time frame: Every study morning

    Perceived auditory fatigue, self-reported on a 5-point verbal scale, from 1 - "Not at all" (best outcome) to 5 - "Extremely" (worst outcome)

Sponsors and collaborators

Lead sponsor

Göteborg University

Other

Collaborators

  • University of Manitoba
  • University of Pennsylvania

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Apr 8, 2022
Registry last updated
Jun 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.